SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003918
Filing Date
2021-11-10
Accepted
2021-11-10 07:31:47
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrx-20210930.htm   iXBRL 10-Q 2561133
2 EX-10.1 tcrx-ex10_1.htm EX-10.1 92370
3 EX-31.1 tcrx-ex31_1.htm EX-31.1 14605
4 EX-31.2 tcrx-ex31_2.htm EX-31.2 14574
5 EX-32.1 tcrx-ex32_1.htm EX-32.1 9015
6 EX-32.2 tcrx-ex32_2.htm EX-32.2 9936
  Complete submission text file 0000950170-21-003918.txt   6871851

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrx-20210930_lab.xml EX-101.LAB 310370
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrx-20210930_pre.xml EX-101.PRE 249028
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrx-20210930_def.xml EX-101.DEF 170779
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrx-20210930.xsd EX-101.SCH 33924
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrx-20210930_cal.xml EX-101.CAL 26534
12 EXTRACTED XBRL INSTANCE DOCUMENT tcrx-20210930_htm.xml XML 952752
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40603 | Film No.: 211394414
SIC: 2836 Biological Products, (No Diagnostic Substances)